Clinical Study

A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101

Posted Date: Jun 12, 2019

  • Investigator: Brian Moseley
  • Specialties: Epilepsy, Neurology
  • Type of Study: Drug

The purpose of this study is to investigate the safety and effectiveness of a new antiseizure drug called XEN1101 in patients with partial (aka focal) onset seizures that haven't responded to 1-3 other antiseizure drugs.


Male And Female Patients Between 18 And 75 Years Of Age, Diagnosed With Partial (Aka Focal) Epilepsy And Still Having 4 Or More Partial Seizures Per Month Despite Treatment With 1-3 Other Antiseizure Drugs.


Epilepsy, Seizure

For More Information:

Donna Schwieterman

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.